as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
7.12%
Downside
0.50%
Upside
52 Week's Low
52 Week's High
69.70%
Downside
37.09%
Upside
Check Immunitybio Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.1B
EPS (TTM)
-0.4033
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.43
Industry PE ratio
5.383461538461538
PEG Ratio
0EBITDA
-244.9M
Revenue (TTM)
82.6M
Profit Margin
0.00%
Return On Equity TTM
0.00%
Track how Immunitybio Inc. P/E has moved over time to understand its valuation trends.
Immunitybio Inc. in the last 5 years
Lowest (-34.68x)
March 31, 2021
Today (-4.43x)
February 7, 2026
Industry (5.38x)
February 7, 2026
Highest (-1.91x)
September 30, 2023
Today’s Price to Earnings Ratio: -4.43x
Compare market cap, revenue, PE, and other key metrics of Immunitybio Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $6.1B | NA | -4.43 | 0.00% | |
| BUY | $122.3B | 122.02% | 33.56 | 31.35% | |
| BUY | $47.7B | 98.75% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 57.42% | 18.28 | 32.13% |
The Immunitybio Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Immunitybio Inc. investment value today
Current value as on today
₹1,83,284
Returns
₹83,284
(+83.28%)
Returns from Immunitybio Inc. Stock
₹79,762 (+79.76%)
Dollar Returns*
₹3,522 (+3.52%)
Based on 8 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Immunitybio Inc.. Average target price of $11.8
Get share price movements and forecasts by analysts on Immunitybio Inc..
What analysts predicted
48.81%UPSIDE
Target Price
$11.8
Current Price
$6.04
Analyzed by
8 Analysts
Target
$11.80
Immunitybio Inc. target price $11.8, a slight upside of 48.81% compared to current price of $6.04. According to 8 analysts rating.
Investment in Immunitybio Inc. Shares on INDmoney has grown by 537.05% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:537.05% versus previous 30 day period
Search interest for Immunitybio Inc. Stock has increased by 1068% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1068% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 20 January
Tue, 11:49 PM
-ImmunityBio shares rise after FDA's constructive feedback on Anktiva's label expansion plans for bladder cancer therapy.
Wed, 00:17 AM
-ImmunityBio stock surges 20.44% after announcing plans to submit additional data to the FDA for Anktiva's application.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, IBRX stock has moved up by 170.1%
Best in 3 Years
![]()
In the last 3 years, IBRX has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
![]()
In the last 1 year, IBRX has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
![]()
Revenue is up for the last 7 quarters, 40.0K → 32.06M (in $), with an average increase of 51.3% per quarter
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -129.64M → -67.25M (in $), with an average increase of 38.9% per quarter
| Organisation | Immunitybio Inc. |
| Headquarters | 3530 John Hopkins Court, San Diego, CA, United States, 92121 |
| Industry | Healthcare |
| CEO | Mr. Richard Gerald Adcock |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Regan J. Lauer | Chief Accounting Officer |
Ms. Sarah Singleton | Chief Communications Officer & Head of Patient Advocacy |
Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., M.S., M.Sc. | Executive Chairman of the Board and Global Chief Scientific & Medical Officer |
Mr. Richard Gerald Adcock | President, CEO & Director |
Dr. Enrique Diloné Ph.D., RAC | Chief Technology Officer |
Ms. Emily Arison | Senior Vice President of Human Resources |
Dr. Leonard S. Sender M.D. | Chief Medical Officer of Liquid Tumors & Cell Therapy |
Dr. Sandeep K. Reddy M.D. | Chief Medical Officer |
Mr. David C. Sachs | Chief Financial Officer |
Dr. Barry J. Simon M.D. | Chief Corporate Affairs Officer & Director |
Immunitybio Inc. share price today is $6.04 as on at the close of the market. Immunitybio Inc. share today touched a day high of $6.07 and a low of $5.61.
Immunitybio Inc. share touched a 52 week high of $8.28 on and a 52 week low of $1.83 on . Immunitybio Inc. stock price today i.e. is closed at $6.04,which is 27.05% down from its 52 week high and 230.05% up from its 52 week low.
Immunitybio Inc. market capitalisation is $0.01T as on .
Indian investors can start investing in Immunitybio Inc. (IBRX) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Immunitybio Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Immunitybio Inc. share’s latest price of $6.04 as on February 7, 2026 at 2:29 am IST, you will get 1.6556 shares of Immunitybio Inc.. Learn more about
fractional shares .